164
Participants
Start Date
September 30, 2021
Primary Completion Date
September 30, 2026
Study Completion Date
September 30, 2026
Nedaplatin
Nedaplatin is a second-generation platinum-like derivative, which is a cell cycle non-specific drug, with a mechanism of action and efficacy similar to cisplatin, and a wide anti-cancer spectrum
Cisplatin
Cisplatin, aka cis-dichlorodiamineplatin, is a platinum-containing anticancer drug
The Affiliated Cancer Hospital of Guizhou Medical University, Guiyang
Guiyang Medical University
OTHER